We are able to create mammalian metabolites of more complex structures as featured in our May 2014 newsletter, here using using Cyclosporin A as an example. We do this using our microbial biotransformation and PolyCYPs enzymes. In addition, we are also able to produce microbial specific metabolites which may have interesting, exploitable properties that have not previously been possible to explore.

Q3 2026 Newsletter – Gut metabolism, PROTAC MetID update and latest blog
Q3 2026 newsletter – Gut metabolism, PROTAC MetID update and latest blog Explore the latest from Hypha in our Q3 2026 newsletter: 💡 Highlights Gut
Read More >